Morning Symposia

Learn about clinical breakthroughs and advances that lead to better patient care during these thought-provoking presentations. Each session is presented by leading experts in critical care and offers a thorough analysis of the developments and controversies affecting most intensive care unit environments. These sessions, supported by educational grants, are complimentary for all Congress registrants; no additional registration is needed to attend. 

Continental breakfast will be provided for symposia attendees beginning at 5:45.

View the 48th Critical Care Congress Special Events and Sessions Brochure.

Catecholamine-Resistant Distributive Shock: Current Management
Supported by an educational grant from La Jolla Pharmaceutical Company
Moderator: Addison K. May

Monday, February 18, 2019
6:15 a.m. - 7:45 a.m.
Room: Ballroom 20D, San Diego Convention Center

Session Talks

  • Pathophysiology of Catecholamine-Resistant Distributive Shock
    • Steven M. Hollenberg
  • Epidemiology of Disease: Prevalence and Burden of Disease, Mortality, and Implications for Therapy
    • Timothy E. Albertson
  • Angiotensin II: A Novel Therapeutic Option
    • Azra Bihorac
  • Case Study
    • Addison K. May
​Learning Objectives
  • Discuss how and why catecholamines fail as therapy for distributive shock 
  • Interpret the latest clinical trials and rationale for use of angiotensin II
  • Review the epidemiology of catecholamine-resistant distributive shock

New Opportunities to Improve ICU Patient Outcomes: The Role of Parenteral Nutrition and New Lipids
Supported by an educational grant from Fresenius Kabi USA
Moderator: Paul Wischmeyer

Tuesday, February 19, 2019
6:15 a.m. - 7:45 a.m.
Room: Ballroom 20D, San Diego Convention Center

Session Talks

  • Dispelling Myths of Parenteral Nutrition: Improving Outcomes; Focus on Safety
    • Paul Wischmeyer
  • Overview of Lipid Emulsions
    • Ashley D. DePriest
  • Pragmatic Approaches to Achieving Lipid Emulsion Availability in Healthcare Institutions
    • Todd W. Canada, Paul Wischmeyer
  • Case Discussions/Panel Discussion
    • Todd W. Canada, Ashley D. DePriest, Paul Wischmeyer
​Learning Objectives
  • Summarize new data demonstrating the safety of parenteral nutrition (PN) in critical illness
  • Compare physiologic effects, efficacy, and safety of lipids used in PN
  • List key strategies to advocate for inclusion of new lipids in hospital formularies
  • Demonstrate appropiate use of lipid formulations in critically ill patients requiring PN